Novo Nordisk Inc. lobbies on its own behalf. For Q3 2026 it reported $2.01M across 1 client report and lists 5 lobbyists across its filings. Issues include Budget/Appropriations, Copyright/Patent/Trademark, Health Issues and Medicare/Medicaid.
| Client | Reported | Issues |
|---|---|---|
| NOVO NORDISK INC. | $2.01M | Budget/Appropriations, Copyright/Patent/Trademark, Health Issues |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $4.60M | 1 |
| 2025 | $7.23M | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.